Safety and Effectiveness of A Novel Continuous Glucose and Ketone Monitoring System

ConditionType1diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHenan University of Science and Technology

About this trial

The study is to evaluate the accuracy and safety of a novel real-time continuous glucose and ketone monitoring system among adult patients with type 1 diabetes mellitus (T1DM) with respect to Yellow Spring Instrument (YSI) and Randox reference venous plasma sample measurements.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Diagonsed with T1DM on Continuous subcutaneous insulin infusion (CSII)

Venous blood sampling access can be established in the forearm

Capable of independently reading instructions and complying with the clinical trial requirements

Disqualifiers

Severe hypoglycemia within the past 6 months

A diagnosed history of Diabetic ketoacidosis (DKA) in the past 3 months

Heart failure or hemiplegic sequelae due to prior cerebrovascular disease

Severe skin conditions at the sensor wear site

Trial design

Treatments tested in this trial

  • GK5 CGKM

Treatment groups

12 Participants
are divided into 1 treatment group

Locations

2
The First Hospital of Hebei Medical University050000, ShijiazhuangHebei, China
Henan University of Science and Technology471003, LuoyangHenan, China

Sponsors and collaborators

Henan University of Science and Technology

Lead sponsor